Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 01, 1999; 53 (2) Brief Communications

Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome

R.A. J. A. M. Bernsen, A.E. J. de Jager, P.I. M. Schmitz, F.G. A. van der Meché
First published July 1, 1999, DOI: https://doi.org/10.1212/WNL.53.2.409
R.A. J. A. M. Bernsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.E. J. de Jager
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.I. M. Schmitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.G. A. van der Meché
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome
R.A. J. A. M. Bernsen, A.E. J. de Jager, P.I. M. Schmitz, F.G. A. van der Meché
Neurology Jul 1999, 53 (2) 409; DOI: 10.1212/WNL.53.2.409

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
3

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Article abstract Three to six years after onset of Guillain-Barré syndrome, 63% of 122 patients showed one or more changes in their lifestyle, work, or leisure activities, or in the life of their partners. The changes were influenced by an impaired final functional outcome, along with loss of power and poor condition, although physically recovered patients showed these changes as well.

Little is known about long-term changes in the psychosocial status of patients with Guillain-Barré syndrome (GBS). Recently, we described the residual effects of GBS on the health-related quality of life (HRQL) using the Sickness Impact Profile1; a remarkable reduction of HRQL was found, even in patients who showed a good physical recovery. Changes in work, leisure activities, and functioning at home may also occur but have not yet been studied systematically.

We studied psychosocial status in relation to physical status in a group of 122 patients 3 to 6 years after onset of GBS.

Patients and methods.

The patients studied had participated in the Dutch GBS trial, in which treatment with plasma exchange was compared with IV immunoglobulins.2 Of the 150 patients who had participated in the Dutch GBS trial, 139 could be traced, and 134 of them were willing to participate in our study. On admission to the trial, all patients fulfilled the criteria for acute GBS, were still within 2 weeks of onset of the disease, and were unable to walk more than 10 meters without a walker or another person’s support.

Six years after the trial started, these patients were asked to complete a questionnaire. At this time they were between 31 and 77 months postonset of GBS. The questionnaire contained multiple choice questions relating to the contemporary physical condition, to the situation at work and at home, and to leisure activities. If the respondent indicated that a change had occurred, he or she was asked whether the change was due to GBS. Furthermore, the residual neurologic condition was assessed according to the functional assessment scale (F-score), modified from Hughes,3 and a standard neurologic examination was done.

The Kruskal-Wallis test was used for testing the hypothesis that continuous outcomes from three (or more) groups come from the same population. The Mann-Whitney test was used for two groups. Comparison of percentages was performed using the chi-square test.

Results.

Of the 134 participating patients, 6 were excluded because of incomplete data. Six other patients under the age of 16 years were left out of the analysis because their age-related psychosocial circumstances were not the aim of our study. Therefore, 122 patients were available for further analysis.

Eighty-four patients had no (F = 0) or only minor neurologic symptoms or signs (F = 1). Together they made up the group with good recovery. Twenty-four patients showed a moderate recovery (F = 2: able to walk more than 10 meters without assistance), and 14 patients were left with severe residual signs (F = 3: able to walk more than 10 meters only with a walker or support; F = 4: bed- or chairbound).

In table 1, the number of patients who had to change work, mode of living, and leisure activities is indicated. Between 15 and 44% showed changes. The most frequent causes for change in work and leisure activities were loss of power (77% and 71%, respectively) and poor condition (50% and 52%, respectively).

View this table:
  • View inline
  • View popup
Table 1.

Changes in five aspects of psychosocial status

In 63% of the patients, one or more changes in psychosocial status were observed: in 50% of patients with good recovery, in 88% with moderate recovery, and in 100% with severe residual signs.

The influence of the final F-score, muscle power measured with a Medical Research Council sumscore, sensory deficit in arms or legs, and muscle ache on the changes in leisure activities, work, and functioning at home was assessed (table 2). All factors had some effect. Age was of no influence.

View this table:
  • View inline
  • View popup
Table 2.

p Values of significance: tests for association of impairment with leisure activities, work, and functioning at home

Nineteen percent of the patients mentioned sexual problems. Some of these reported only that their sexual activity had decreased. A few gave a more specified answer, mentioning problems with erection and loss of sexual feelings.

Discussion.

In 63% of our patients, one or more aspects of psychosocial status had changed owing to GBS 3 to 6 years after onset of GBS. Lasting changes for the partner were found in 39% of our patients. These results were obtained from patients who were not able to walk more than 10 meters independently during the acute phase. The final physical recovery of our patients is in accordance with reports of other groups.4,5

Residual weakness and sensory deficit are important risk factors, but the psychosocial status had also changed in patients with good physical recovery. In a study of the HRQL in this patient group, it was also found that patients with good recovery could have a disturbed HRQL.1

It is questionable whether the changes are disease specific or related to a severe disease period. The finding of the clinical outcome score as a strong predictor of psychosocial change stresses disease specificity, but a general psychological impact from a severe disease cannot be denied. Our aim, however, was to document the changes in GBS patients to see whether support in the recovery phase should be improved.

GBS caused an alteration in work in more than one third of the patients who had been employed. Most of them did not resume work at all; others got work at a lower level. In a retrospective analysis of a group of patients who needed artificial ventilation, De Jager et al.6 report this number to be 40%. In addition to the physical factors (see table 2), our patients frequently mentioned poor condition as a cause of change in work or leisure activities, especially in patients with good physical recovery. Remarkably, none of the patients with severe residual symptoms complained about poor condition, possibly because their activities were already limited by their handicap. Ropper et al.7 mention that physical fatigue often occurs in the first year of GBS, but that it is rarely disabling. Our systematic results contradicted this impression from a large neurologic clinical series. Our results confirmed a report that despite clinical recovery, patients can continue to have persistent decreases in physical performance.8 Recovery of a GBS patient may not be complete despite normal physical performance.

Furthermore, disturbances of sensation in the arms had a significant influence on work and functioning at home. A trend was found with respect to diminished sensation in the hands and the feet for leisure activities. In addition, muscle ache had a highly significant influence on leisure activities and functioning at home.

Nineteen percent also mentioned sexual problems. This is a problem that might be overlooked easily in this group of patients.

Acknowledgments

Supported by the foundation “De Drie Lichten,” the Netherlands.

  • Received December 31, 1998.
  • Accepted April 3, 1999.

References

  1. ↵
    Bernsen RAJAM, Jacobs HM, de Jager AEJ, van der Meché FGA. Residual health status after Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1997;62:637–640.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Van der Meché FGA, Schmitz PIM, for the Dutch Guillain-Barré study group. High-dose immunoglobulin versus plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123–1129.
    OpenUrlPubMed
  3. ↵
    Hughes RAC, Newson-Davis JM, Perkins GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978;ii:50–53.
    OpenUrl
  4. ↵
    Raphael JC, Masson C, Morice V, et al. The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases. Rev Neurol 1986;142:613–624.
    OpenUrlPubMed
  5. ↵
    Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51:605–612.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    De Jager AEJ, Minderhoud JM. Residual signs in severe Guillain-Barré syndrome : analysis of 57 patients. J Neurol Sci 1991;104:151–156.
    OpenUrlCrossRefPubMed
  7. ↵
    Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia:F.A. Davis, 1991.
  8. ↵
    Burrows DS, Cuetter AC. Residual subclinical impairment in patients who totally recovered from Guillain-Barré syndrome : impact on military performance. Military Medicine 1990;155:438–440.
    OpenUrlPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Patients and methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise